1. Home
  2. Analysis
  3. Benzonatate
  4. Bosulif

Benzonatate and Bosulif drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benzonatate (benzonatate) and Bosulif (bosutinib). Common drug interactions include retching among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Benzonatate and Bosulif. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Benzonatate?

Benzonatate has active ingredients of benzonatate. It is often used in cough. eHealthMe is studying from 17,274 Benzonatate users. Check the latest studies of Benzonatate.

What is Bosulif?

Bosulif has active ingredients of bosutinib. eHealthMe is studying from 9,401 Bosulif users. Check the latest studies of Bosulif.

On Jul, 21, 2026

14 people who take Benzonatate and Bosulif together, and have interactions are studied.

Benzonatate and Bosulif drug interactions.

What are the common drug interactions of Benzonatate and Bosulif, by gender? *:

female:

  1. Retching (strong involuntary effort to vomit)
  2. Back pain
  3. Haemorrhage (bleeding)
  4. Neck pain
  5. Pain
  6. Pain in extremity
  7. Pain in jaw
  8. Rash
  9. Diarrhoea
  10. Headache (pain in head)

male:

  1. Abdominal pain
  2. Dyspnoea exertional (breathlessness or shortness of breath)
  3. Fatigue (feeling of tiredness)
  4. Infection
  5. Pleural effusion (water on the lungs)
  6. Surgery
  7. Tumour marker increased

What are the common drug interactions of Benzonatate and Bosulif, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Diarrhoea
  2. Gastric disorder (disease of stomach)
  3. Vomiting

50-59:

  1. Headache (pain in head)
  2. Nausea (feeling of having an urge to vomit)
  3. Diarrhoea
  4. Vomiting

60+:

  1. Vomiting
  2. Dehydration (dryness resulting from the removal of water)
  3. Rash
  4. Abdominal pain
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Fatigue (feeling of tiredness)
  7. Tumour marker increased
  8. Urinary tract infection
  9. Nausea (feeling of having an urge to vomit)
  10. Retching (strong involuntary effort to vomit)

What are the existing conditions these people have? *

  1. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 10 people, 71.43%
  2. Asthma: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Benzonatate and Bosulif?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Benzonatate and Bosulif:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Benzonatate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bosulif:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benzonatate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bosulif and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on benzonatate and bosutinib (the active ingredients of Benzonatate and Bosulif, respectively), and Benzonatate and Bosulif (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.